TheEdgeResearch
Home / Stocks / ABBV

AbbVie Inc. (ABBV)

NYSE Healthcare Drug Manufacturers - General
$244.22 ▼ -0.23%
Market Cap
$431.49B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.28
52-Wk Range
184.63-261.64
CEO
Robert A. Michael
Country
US
Currency
USD

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCL…

Open full interactive analysis & DCF →